hydrALAZINE HYDROCHLORIDE INJECTION — Class II drug recall D-0668-2017
Terminated recall by Mckesson Medical Surgical, reported 2017-04-19, distributed nationwide. Temperature Abuse: Certain pieces of these lots distributed by McKesson Medical Surgical Inc. were inadvertent
| Recall number | D-0668-2017 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Mckesson Medical Surgical, Henrico, VA, United States |
| Recall initiated | 2017-03-08 |
| Classified | 2017-04-12 |
| Reported by FDA | 2017-04-19 |
| Terminated | 2024-08-19 |
| Distributed | Nationwide (US) |
| Quantity | 98 vials |
| Reason classes | labeling, temperature control |
| NDC | 63323-0614, 63323-0614-00, 63323-0614-01 |
| Lot numbers | 05/18, 6114311, 6114717 |
Product
hydrALAZINE HYDROCHLORIDE INJECTION, USP, 20 mg/mL, 1 mL Single Dose Vial, packaged in 25 Vials per carton, Rx only, APP Fresenius Kabi USA, LLC, Lake Surich, IL 60047, NDC 63323-614-01, Distributed by McKesson Medical-Surgical, Inc.
Reason for recall
Temperature Abuse: Certain pieces of these lots distributed by McKesson Medical Surgical Inc. were inadvertently stored refrigerated rather than the labeled room temperature recommendation.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0668-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.